Chinese expert consensus on refined diagnosis, treatment, and management of advanced primary liver cancer (2023 edition)

Chinese expert consensus on refined diagnosis, treatment, and management of advanced primary liver cancer (2023 edition)

Hepatocellular carcinoma (HCC), commonly known as primary liver cancer, is a major cause of malignant tumors and cancer-related deaths in China, accounting for approximately 85% of all cancer cases in the country. Several guidelines have been used to diagnose and treat liver cancer. However, these g...

ver descrição completa

Detalhes bibliográficos
Main Authors: Xiufeng Liu, Feng Xia, Yue Chen, Huichuan Sun, Zhengqiang Yang, Bo Chen, Ming Zhao, Xinyu Bi, Tao Peng, Aizier Ainiwaer, Zhiwen Luo, Fusheng Wang, Yinying Lu
Formato: Artigo
Idioma:English
Publicado em: KeAi Communications Co., Ltd. 2024-06-01
Colecção:Liver Research
Assuntos:
Hepatocellular carcinoma (HCC)
Targeted therapy
Immunotherapy
Refined diagnosis and treatment
Expert consensus
Acesso em linha:http://www.sciencedirect.com/science/article/pii/S2542568424000163

Internet

http://www.sciencedirect.com/science/article/pii/S2542568424000163

Registos relacionados